Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.76−0.23 (-7.69%)
Close on Nov 17, 2026Market cap $113.34MP/E –Yield –
Scienture r&d expenses
Research and development expenses are spending on new products and technology.
Scienture's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.50M, down 31.6% year over year. For fiscal 2025 it was $1.96M, down 12.5% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.96M | -12.5% |
| FY2024 | Dec 31, 2024 | $2.24M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.17M | +38.3% |
| Q1 FY2026 | Mar 31, 2026 | $793.98K | +38.2% |
| Q4 FY2025 | Dec 31, 2025 | $368.70K | -62.5% |
| Q3 FY2025 | Sep 30, 2025 | $169.34K | -86.5% |
| Q2 FY2025 | Jun 30, 2025 | $843.55K | – |
| Q1 FY2025 | Mar 31, 2025 | $574.68K | – |
| Q4 FY2024 | Dec 31, 2024 | $982.71K | – |
| Q3 FY2024 | Sep 30, 2024 | $1.25M | – |
See a number that looks wrong?